USDA reports the latest foodborne risks in terms of annual costs and deaths. Norovirus, second only to the common cold in prevalence, is not normally considered a killer but in reality ranks #4.
It is the season to take action. Consider Emory University’s research that identifies Purell VF-481 as an effective norovirus intervention and is as kind to skin as baby oil.
ServeReady® Hands can win over norovirus.
The 15 costliest foodborne pathogens are as follows:
The Billion Dollar Bugs:
- Salmonella – $3.7 billion; 1,027,561 total cases; 19,336 hospitalized; 378 deaths
- Toxoplasma gondii – $3.3 billion; 86,686 cases; 4,428 hospitalized; 343 deaths
- Listeria monocytogenes – $2.8 billion; 1,591 cases; 1,173 hospitalized; 306 deaths
- Norovirus – $2.3 billion; 5,461,731 cases; 14,663 hospitalized; 149 deaths
- Campylobacter – $1.9 billion; 845,024 cases; 8,463 hospitalized; 76 deaths
The Million Dollar Pack:
- Clostridium perfringens – $343 million; 965,958 cases; 438 hospitalized; 26 deaths
- Vibrio vulnificus - $320 million; 96 cases; 93 hospitalized; 36 deaths
- Yersinia enterocolitica - $278 million; 97,656 cases; 480 hospitalized; 29 deaths
- E. coli O157 – $271 million; 63,153 cases; 2,138 hospitalized; 30 deaths
- Vibrio (all other non-cholera species) - 17,564 cases; 83 hospitalized; 8 deaths
- Shigella – $138 million; 131,254 cases; 1,456 hospitalized; 10 deaths
- Cryptosporidium – $52 million; 57,616 cases; 210 hospitalized; 4 deaths
- Vibrio parahaemolyticus – $41 million; 34,664 cases; 100 hospitalized; 4 deaths
- E. coli non-O157 – $27 million; 112,752 cases; 271 hospitalized; 1 death
- Cyclospora – $2 million; 11,407 cases; 11 hospitalized; zero deaths
Check out the complete report: http://www.ers.usda.gov/data-products/cost-estimates-of-foodborne-illnesses.aspx
